Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
United States
University of Rochester, Rochester, New York Age range
18 Years and older
Last updated February 2025